supported by the Beijing Double Class One Human Resource Office-High-Level-Jianxun Wang's Research Team Funding Project of China(1000041510155);the Research Startup Fund Program at the Beijing University of Chinese Medicine(90011451310032).
Objective:To investigate the effects and mechanisms of Xuebijing injection(XBJ)on Chimeric antigen receptor-T(CAR-T)cell function and its therapeutic potential against CAR-T therapy-associated cytokine storms(CRS).Met...
Objective:To analyze the therapeutic effect of Xuebijing+antimicrobials in intensive care unit(ICU)patients with severe pneumonia.Methods:60 ICU patients with severe pneumonia from June 2021 to June 2023 were selected...
supported by a grant from National Natural Science Foundation of China (82272196)。
BACKGROUND:This study aims to explore whether Xuebijing(XBJ) can improve intestinal microcirculation dysfunction in sepsis and its mechanism.METHODS:A rat model of sepsis was established by cecal ligation and puncture...
funded by National Natural Science Foundation of China(82192912,82074176,81801935,and 82272187);Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(ZYYCXTD-C-202009);the Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12050306).
Sepsis,a life-threatening health issue,lacks effective medicine targeting the septic response.In China,treatment combining the intravenous herbal medicine XueBiJing with conventional procedures reduces the 28-day mort...
supported by Hunan Province Key Research and Development Program(2020SKC2004).
BACKGROUND:Xuebijing(XBJ)can alleviate the inflammatory response,improve organ function,and shorten the intensive care unit(ICU)stay in patients with pyogenic liver abscess(PLA)complicated with sepsis,but the molecula...
supported by the National Natural Science Foundation of China(Nos.82130001,82200089,8173000,81800077,and 82070045);Shanghai Sailing Program(No.22YF1406100);the National Key R&D Plan(No.2020YFC2003700);the Science and Technology Commission of Shanghai Municipality(Nos.20Z11901000,20DZ2261200,and 20XD1401200);Shanghai Municipal Science and Technology Major Project,Clinical Research Plan of SHDC(No.SHDC2020CR5010-002);Shanghai Municipal Key Clinical Specialty(No.shslczdzk02201).
Acute lung injury/acute respiratory distress syndrome(ALI/ARDS)is characterized by diffuse alveolar injury primarily caused by an excessive inflammatory response.Regrettably,the lack of effective pharmacotherapy curre...
funded by grants from the National Natural Science Foundation of China(Grant Nos.:82074176 and 81503345);Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(Grant No.:ZYYCXTD-C-202009);the National Key R&D Program of China(Grant No.:2018YFC1704500).
XueBiJing is an intravenous five-herb injection used to treat sepsis in China.The study aimed to develop a liquid chromatography-tandem mass spectrometry(LC-MS/MS)-or liquid chromatography-ultraviolet(LC-UV)-based ass...
This work was supported by the Talent Funding Project of Tangshan City in Hebei Province(No.a201902005).
Objective:To observe the effect of Xuebijing,a complex traditional Chinese preparation,on inflammation and prognosis of patients with pneumonia.Methods:The patients with ventilator-associated pneumonia in the intensiv...
This work was supported by start-up funds from Beijing University of Chinese Medicine to Jianxun Wang(grant number 1000041510051).
Sepsis is a life-threatening organ dysfunction that is associated with a high risk of death.Xuebijing(XBJ)injection,a Chinese herbal compound preparation,has been widely used for the treatment of sepsis in China.The p...
National natural science foundation of China(No.81201217,31300801)
Objective:To explore the therapeutic effect of Xuebijing on burn patients and its effect on pain and wound healing.Methods:The burn patients treated in our hospital were selected and divided into two groups according ...